Sort   by:  
 Page size 
UnknownSensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials.
Not available
S-EPMC8886919 | biostudies-literature
UnknownSafety, tolerability and immunogenicity of a quadrivalent recombinant norovirus vaccine (Pichia pastoris) in participants six weeks of age or older: Phase I/IIa trial.
Not available
S-EPMC12498370 | biostudies-literature
UnknownSafety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Not available
S-EPMC9937662 | biostudies-literature
UnknownEfficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
Not available
S-EPMC9127771 | biostudies-literature
UnknownSafety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China.
Not available
S-EPMC8780113 | biostudies-literature
UnknownAccuracy of ESAT6-CFP10 skin test compared with tuberculin skin test in a healthy population: a randomized, blind, parallel controlled phase III clinical study.
Not available
S-EPMC11684250 | biostudies-literature
UnknownQuantification of Glycan in Glycoproteins via AUCAgent-Enhanced Analytical Ultracentrifugation
Not available
S-EPMC12943701 | biostudies-literature
UnknownSafety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Not available
S-EPMC7990482 | biostudies-literature
Sort   by:  
 Page size